The Wockhardt Group, once a prominent player in the pharmaceutical industry, is facing monumental challenges. With mounting debts and a struggling business, the group's substantial assets are now scheduled for auction. This sudden shift in fortunes has sent shockwaves through the industry, leaving many observers. It remains to be seen who will ult